People: Novartis AG (NVS)

NVS on New York Consolidated

74.15USD
17 May 2013
Price Change (% chg)

$-0.86 (-1.15%)
Prev Close
$75.01
Open
$73.53
Day's High
$74.16
Day's Low
$73.50
Volume
1,092,063
Avg. Vol
1,584,517
52-wk High
$75.67
52-wk Low
$51.20

Search Stocks

Fishman, Mark 

Brief Biography

Dr. Mark C. Fishman, M.D., has served as Member of the Executive Committee and President of Novartis Institute for BioMedical Research (NIBR) at Novartis AG since 2002. Before joining Novartis in 2002, Dr. Fishman was Chief of Cardiology and Director of the Cardiovascular Research Center at Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School, both in the United States. Dr. Fishman has worked with national policy and scientific committees, including those of the United States National Institutes of Health (NIH) and the Wellcome Trust. He completed his internal medicine residency, chief residency and cardiology training at Massachusetts General Hospital. Dr. Fishman graduated with a bachelors degree from Yale College in 1972 and a Doctorate of Medicine (M.D.) from Harvard Medical School in 1976. He has been honored with awards and distinguished lectureships, and is Member of the Institute of Medicine of the National Academies (the United States) and a Fellow of the American Academy of Arts and Sciences.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,980,000 5,507,070 361,151 7,848,220

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Daniel Vasella

13,067,600

Joseph Jimenez

13,228,200

Ulrich Lehner

853,107

Jonathan Symonds

4,646,210

Felix Ehrat

3,584,790

Juergen Brokatzky-Geiger

3,474,440
As Of 30 Dec 2012
Search Stocks